Tobias Maile

Tobias Maile has extensive work experience in the field of mass spectrometry and proteomics. Tobias has worked as a Principal Scientist at Loxo Oncology at Lilly since 2021. Prior to that, they held roles at CalicoLabs as a Principal Research Associate and Senior Research Associate, where they supported key research groups with mass spectrometric data analysis and established LCMS technology and methods. Tobias also worked as a Postdoctoral Fellow at Genentech, where they conducted mass spectrometry on epigenetic posttranslational modifications on histones. Additionally, they worked as a Visiting Research Scholar at Princeton University, collaborating on quantitative proteomics and chemical histone sample labeling. Earlier in their career, they were a Postdoctoral Fellow at Cancer Research UK, where they focused on posttranslational modifications of transcription factors and their function in the Hippo pathway.

Tobias Maile's education history includes:

- From 1995 to 2001, they attended the University of Hohenheim as an undergraduate student studying Biology, General.

- From 2002 to 2007, they simultaneously attended the University of California, Riverside as a Junior Specialist in Biochemistry and Molecular Biology, and the University of Hohenheim where they obtained a Doctor of Philosophy (PhD) in Molecular Biology.

In addition to their formal education, Tobias Maile has obtained certifications in Inferential Statistics and Introduction to Probability and Data from Coursera. Tobias also completed a laboratory safety training course according to the German gene-technology safety law at the Universität Hohenheim in Stuttgart-Hohenheim, Germany in February 2002.